Cargando…
Axonal Transport Defects in a Mitofusin 2 Loss of Function Model of Charcot-Marie-Tooth Disease in Zebrafish
Charcot-Marie-Tooth disease (CMT) represents a group of neurodegenerative disorders typically characterised by demyelination (CMT1) or distal axon degeneration (CMT2) of motor and sensory neurons. The majority of CMT2 cases are caused by mutations in mitofusin 2 (MFN2); an essential gene encoding a...
Autores principales: | Chapman, Anna L., Bennett, Ellen J., Ramesh, Tennore M., De Vos, Kurt J., Grierson, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694133/ https://www.ncbi.nlm.nih.gov/pubmed/23840650 http://dx.doi.org/10.1371/journal.pone.0067276 |
Ejemplares similares
-
Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity
por: Beręsewicz, Małgorzata, et al.
Publicado: (2018) -
Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
por: Franco, Antonietta, et al.
Publicado: (2022) -
Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2)
por: Engelfried, Kathrin, et al.
Publicado: (2006) -
Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene
por: Vinci, Paolo, et al.
Publicado: (2011) -
Mutation in PNKP presenting initially as axonal Charcot-Marie-Tooth disease
por: Pedroso, José Luiz, et al.
Publicado: (2015)